Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Stephens & Co. Reiterates Overweight on Sysco, Maintains $90 Price Target

Stephens & Co. Reiterates Overweight on Sysco, Maintains $90 Price Target

Stephens & Co. analyst Joshua Long reiterates Sysco (NYSE:SYY) with a Overweight and maintains $90 price target.

byBenzinga Newsdesk

January 13, 2023

1 minute read

Stephens & Co. analyst Joshua Long reiterates Sysco (NYSE:SYY) with a Overweight and maintains $90 price target.

Barclays Maintains Equal-Weight on Paycom Software, Raises Price Target to $336

By Benzinga Newsdesk

February 8, 10:53 AM

Barclays analyst Raimo Lenschow maintains Paycom Software (NYSE:PAYC) with a Equal-Weight and raises the price target from $324 to $336.

PAYC

Cosmos Holdings Late Monday Issued A Filing Showing An Offering Of $12M Of Shares Of Common Stock

By Benzinga Newsdesk

September 20, 2:12 PM

- SEC filing

COSM

Waymo Cars Cause Traffic Chaos In San Francisco Fog Weeks After Cruise Crash

By Anan Ashraf

April 13, 1:11 AM

On Tuesday morning, five self-driving Waymo vehicles reportedly pulled over in San Francisco’s Balboa Terrace due to dense fog, causing…

Morgan Stanley Maintains Equal-Weight on Vertex Pharmaceuticals, Raises Price Target to $286

By Benzinga Newsdesk

January 24, 10:33 AM

Morgan Stanley analyst Matthew Harrison maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Equal-Weight and raises the price target from $285 to $286.

VRTX

Stephens & Co. Reiterates Overweight on Sysco, Maintains $90 Price Target

Related Posts

Barclays Maintains Equal-Weight on Paycom Software, Raises Price Target to $336

Cosmos Holdings Late Monday Issued A Filing Showing An Offering Of $12M Of Shares Of Common Stock

Waymo Cars Cause Traffic Chaos In San Francisco Fog Weeks After Cruise Crash

Morgan Stanley Maintains Equal-Weight on Vertex Pharmaceuticals, Raises Price Target to $286